Kiniksa Pharmaceuticals International Stock Forecast
NASDAQ: KNSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 79.78 0.00%
KNSA analyst consensus
Consensus (8 analysts)
strong_buy
Avg. price target
$98.00+22.84%
- Strong buy 1
- Buy 7
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 8 Wall Street analysts covering Kiniksa Pharmaceuticals International (2026-10-08), 8 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $98.00, with a high estimate of $108.00 and a low estimate of $87.00. The average target implies upside of 22.8% from the current price of $79.78.
The spread between the highest and lowest targets is 24.1%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for KNSA.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 13% |
| Buy | 7 | 88% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $87.00 | +9.05% |
| Average target | $98.00 | +22.84% |
| High target | $108.00 | +35.37% |